You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Jeremy Rifkin Discusses Biotechnology

Listen
Media Options
Listen

Related

    In his provocative and far-reaching work, Jeremy Rifkin argues that the computer revolution is merely a prelude to a far more significant change taking place in the global economy — a historic transition into the Age of Biotechnology.

    The Biotech Century promises genetically engineered plants and animals to feed a hungry world; wonder drugs and genetic therapies to produce healthier babies, eliminate human suffering, and extend the human life span. But with every step we take into this Brave New World, the nagging question persists — At what cost?

    The new genetic commerce raises more troubling questions than any other economic revolution in history. Will the artificial creation of cloned animals mean the end of nature? Will the mass release of thousands of genetically engineered life forms into the environment cause catastrophic damage to the biosphere? What will it mean to live in a world where babies are genetically engineered and customized in the womb? What are the risks we take in attempting to design more “perfect” human beings?

    Guests:

    • Jeremy Rifkin, Jeremy Rifkin is the author of 14 books on economic trends and matters relating to science, technology, and culture, including his latest ??The Biotech Century, published by Tarcher/Putnam Press. He is president of the Foundation on Economic Trends in Washington, D.C.

    ??
    .
    .
    .
    ??

    Related Story

    StoryApr 24, 2024Naomi Klein: Jews Must Raise Their Voices for Palestine, Oppose the “False Idol of Zionism”
    The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

    Non-commercial news needs your support

    We rely on contributions from our viewers and listeners to do our work.
    Please do your part today.
    Make a donation
    Top